Suboptimal exposure to anti-TB drugs in a TBM/HIV+ population is not related to anti-retroviral therapy. (Clinical Pharmacology and Therapeutics, 2017)

(untitled) - Hien, T; Farrar, J; Török, M; Aljayyoussi, G; Waterhouse, D; Chau, T; Mai, N; Phu, N; Hope, W; Ward, S